Herbal medicines and chronic kidney disease

Nephrology

Volumn 15, Issue SUPPL. 2, 2010, Pages 10-17

  Jha, Vivekanand ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Alternative medicines; Aristolochic acid nephropathy; Balkan endemic nephropathy; Chronic kidney disease; Herbs; Natural medicines

Indexed keywords

ARISTOLOCHIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HERBACEOUS AGENT; STEROID; PLANT MEDICINAL PRODUCT;

ARISTOLOCHIC ACID NEPHROPATHY; AWARENESS; BALKAN ENDEMIC NEPHROPATHY; CARCINOGENESIS; CHROMATOGRAPHY; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; DETOXIFICATION; HERBAL MEDICINE; HUMAN; INCIDENCE; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RURAL POPULATION; SYMPTOMATOLOGY; URINALYSIS; DRUG INDUSTRY; KIDNEY FAILURE, CHRONIC; PHYTOTHERAPY; PROCEDURES; TREATMENT OUTCOME;

DRUG INDUSTRY; HERBAL MEDICINE; HUMANS; KIDNEY FAILURE, CHRONIC; PHYTOTHERAPY; PLANT PREPARATIONS; TREATMENT OUTCOME;

EID: 77952592590     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2010.01305.x     Document Type: Conference Paper

References (91)

1. Taylor L. Plant Based Drugs and Medicines. Available at: http://www.rain-tree.com/plantdrugs.htm. [accessed 3 October 2009].
2. Jha V, Rathi M. Natural medicines causing acute kidney injury. Semin. Nephrol. 2008 28 : 416 428. (Pubitemid 351952291)
3. Luyckx VA, Naicker S. Acute kidney injury associated with the use of traditional medicines. Nat. Clin. Pract. Nephrol. 2008 4 : 664 671.
4. Brandt HD, Muller GJ. Traditional medicines and acute poisoning. CME 1995 13 : 1053 1060.
5. Hutchins A. Observations in plant usage in Xhosa and Zulu medicines. Bothalia 1989 19.
6. Steenkamp V. Traditional herbal remedies used by South African women for gynaecological complaints. J. Ethnopharmacol. 2003 86 : 97 108.
7. Chen FP, Chen TJ, Kung YY et al. Use frequency of traditional Chinese medicine in Taiwan. BMC Health Serv. Res. 2007 7 : 26.
8. Gogtay NJ, Bhatt HA, Dalvi SS, Kshirsagar NA. The use and safety of non-allopathic Indian medicines. Drug Saf. 2002 25 : 1005 1019.
9. Association BM. Complementary Medicine. New Approaches to Good Practice.
10. De Smet PA. Is there any danger in using traditional remedies? J. Ethnopharmacol. 1991 32 : 43 50.
11. Eisenberg DM, Davis RB, Ettner SL et al. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA 1998 280 : 1569 1575.
12. Straus SE. Herbal medicines - What's in the bottle? N. Engl. J. Med. 2002 347 : 1997 1998.
13. De Smet PA. Herbal medicine in Europe - relaxing regulatory standards. N. Engl. J. Med. 2005 352 : 1176 1178.
14. MacLennan AH, Wilson DH, Taylor AW. Prevalence and cost of alternative medicine in Australia. Lancet 1996 347 : 569 573.
15. Anon. Herbal Drug Market Expanding. Available at: http://sntpost.stii. dost.gov.ph/frames/jantomar05/pg14-herbal-drug.htm. [accessed 2 October 2009].
16. Jha V, Chugh KS. Nephropathy associated with animal, plant, and chemical toxins in the tropics. Semin. Nephrol. 2003 23 : 49 65.
17. Gabardi S, Munz K, Ulbricht C. A review of dietary supplement-induced renal dysfunction. Clin. J. Am. Soc. Nephrol. 2007 2 : 757 765.
18. Isnard Bagnis C, Deray G, Baumelou A, Le Quintrec M, Vanherweghem JL. Herbs and the kidney. Am. J. Kidney Dis. 2004 44 : 1 11.
19. Nortier JL, Vanherweghem JL. For patients taking herbal therapy - lessons from aristolochic acid nephropathy. Nephrol. Dial. Transplant. 2007 22 : 1512 1517.
20. Evan AP, Gardner KD Jr. Nephron obstruction in nordihydroguaiaretic acid-induced renal cystic disease. Kidney Int. 1979 15 : 7 19.
21. Smith AY, Feddersen RM, Gardner KD, Jr., Davis CJ, Jr. Cystic renal cell carcinoma and acquired renal cystic disease associated with consumption of chaparral tea: A case report. J. Urol. 1994 152 : 2089 2091.
22. Ishikawa S, Kato M, Tokuda T et al. Licorice-induced hypokalemic myopathy and hypokalemic renal tubular damage in anorexia nervosa. Int. J. Eat. Disord. 1999 26 : 111 114.
23. Sandler B, Aronson P. Yohimbine-induced cutaneous drug eruption, progressive renal failure, and lupus-like syndrome. Urology 1993 41 : 343 345.
24. Schwarz A. Beethoven's renal disease based on his autopsy: A case of papillary necrosis. Am. J. Kidney Dis. 1993 21 : 643 652.
25. Schmid B, Kotter I, Heide L. Pharmacokinetics of salicin after oral administration of a standardised willow bark extract. Eur. J. Clin. Pharmacol. 2001 57 : 387 391.
26. Segasothy M, Swaminathan M, Kong NC, Bennett WM. Djenkol bean poisoning (djenkolism): An unusual cause of acute renal failure. Am. J. Kidney Dis. 1995 25 : 63 6.
27. Blau JJ. Ephedrine nephrolithiasis associated with chronic ephedrine abuse. J. Urol. 1998 160 : 825.
28. Powell T, Hsu FF, Turk J, Hruska K. Ma-huang strikes again: Ephedrine nephrolithiasis. Am. J. Kidney Dis. 1998 32 : 153 159.
29. Fang HC, Lee PT, Lu PJ et al. Mechanisms of star fruit-induced acute renal failure. Food Chem. Toxicol. 2008 46 : 1744 1752.
30. Terris MK, Issa MM, Tacker JR. Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis. Urology 2001 57 : 26 9.
31. Farrell J, Campbell E, Walshe JJ. Renal failure associated with alternative medical therapies. Ren. Fail. 1995 17 : 759 764.
32. Conz PA, La Greca G, Benedetti P, Bevilacqua PA, Cima L. Fucus vesiculosus: A nephrotoxic alga? Nephrol. Dial. Transplant. 1998 13 : 526 527.
33. Kwan TH, Tong MK, Leung KT et al. Acute renal failure associated with prolonged intake of slimming pills containing anthraquinones. Hong Kong Med. J. 2006 12 : 394 397.
34. Vanherweghem JL, Depierreux M, Tielemans C et al. Rapidly progressive interstitial renal fibrosis in young women: Association with slimming regimen including Chinese herbs. Lancet 1993 341 : 387 391.
35. Cheung TP, Xue C, Leung K, Chan K, Li CG. Aristolochic acids detected in some raw Chinese medicinal herbs and manufactured herbal products - A consequence of inappropriate nomenclature and imprecise labelling? Clin. Toxicol. (Phila.) 2006 44 : 371 378.
36. Vanhaelen M, Vanhaelen-Fastre R, But P, Vanherweghem JL. Identification of aristolochic acid in Chinese herbs. Lancet 1994 343 : 174.
37. Arlt VM, Alunni-Perret V, Quatrehomme G et al. Aristolochic acid (AA)-DNA adduct as marker of AA exposure and risk factor for AA nephropathy-associated cancer. Int. J. Cancer 2004 111 : 977 980.
38. Arlt VM, Pfohl-Leszkowicz A, Cosyns J, Schmeiser HH. Analyses of DNA adducts formed by ochratoxin A and aristolochic acid in patients with Chinese herbs nephropathy. Mutat. Res. 2001 494 : 143 150.
39. Bieler CA, Stiborova M, Wiessler M, Cosyns JP, de Strihou C, Schmeiser HH. 32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy. Carcinogenesis 1997 18 : 1063 1067.
40. Cosyns JP, Jadoul M, Squifflet JP, Wese FX, van Ypersele de Strihou C. Urothelial lesions in Chinese-herb nephropathy. Am. J. Kidney Dis. 1999 33 : 1011 1017.
41. Nortier JL, Martinez MC, Schmeiser HH et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N. Engl. J. Med. 2000 342 : 1686 1692.
42. Solez K, Daugirdas J, Gregory MC et al. Is 'Chinese herbs nephropathy' a prejudicial term? Am. J. Kidney Dis. 2001 38 : 1141 1142.
43. Chen W, Chen Y, Li A. [The clinical and pathological manifestations of aristolochic acid nephropathy - The report of 58 cases]. Zhonghua Yi Xue Za Zhi 2001 81 : 1101 1105.
44. Li X, Yang L, Yu Y. [An analysis of the clinical and pathological characteristics of mu-tong (a Chinese herb) induced tubulointerstitial nephropathy]. Zhonghua Nei Ke Za Zhi 2001 40 : 681 687.
45. Yang CS, Lin CH, Chang SH, Hsu HC. Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs. Am. J. Kidney Dis. 2000 35 : 313 318.
46. Yang HY, Lin JL, Chen KH, Yu CC, Hsu PY, Lin CL. Aristolochic acid-related nephropathy associated with the popular Chinese herb Xi Xin. J. Nephrol. 2006 19 : 111 114.
47. Lai MN, Lai JN, Chen PC et al. Increased risks of chronic kidney disease associated with prescribed Chinese herbal products suspected to contain aristolochic acid. Nephrology (Carlton) 2009 14 : 227 234.
48. Guh JY, Chen HC, Tsai JF, Chuang LY. Herbal therapy is associated with the risk of CKD in adults not using analgesics in Taiwan. Am. J. Kidney Dis. 2007 49 : 626 633.
49. Hong YT, Fu LS, Chung LH, Hung SC, Huang YT, Chi CS. Fanconi's syndrome, interstitial fibrosis and renal failure by aristolochic acid in Chinese herbs. Pediatr. Nephrol. 2006 21 : 577 579.
50. Nortier JL, Vanherweghem JL. Renal interstitial fibrosis and urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). Toxicology 2002 181-182 : 577 580.
51. Cosyns JP, Dehoux JP, Guiot Y et al. Chronic aristolochic acid toxicity in rabbits: A model of Chinese herbs nephropathy? Kidney Int. 2001 59 : 2164 2173.
52. Yuan M, Shi YB, Li ZH et al. De novo urothelial carcinoma in kidney transplant patients with end-stage aristolochic acid nephropathy in China. Transplant. Proc. 2009 41 : 1619 1623.
53. Arlt VM, Stiborova M, vom Brocke J et al. Aristolochic acid mutagenesis: Molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer. Carcinogenesis 2007 28 : 2253 2261.
54. Bamias G, Boletis J. Balkan nephropathy: Evolution of our knowledge. Am. J. Kidney Dis. 2008 52 : 606 616.
55. Ivic M. Etiology of endemic nephropathy. Lijec. Vjesn. 1969 91 : 1273 1281.
56. Bacchetta J, Dubourg L, Juillard L, Cochat P. Non-drug-induced nephrotoxicity. Pediatr. Nephrol. 2009 24 : 2291 2300.
57. Grollman AP, Jelakovic B. Role of environmental toxins in endemic (Balkan) nephropathy. October 2006, Zagreb, Croatia. J. Am. Soc. Nephrol. 2007 18 : 2817 2823.
58. Karmaus W, Dimitrov P, Simeonov V, Tsolova S, Bonev A, Georgieva R. Metals and kidney markers in adult offspring of endemic nephropathy patients and controls: A two-year follow-up study. Environ. Health 2008 7 : 11.
59. Pfohl-Leszkowicz A, Tozlovanu M, Manderville R, Peraica M, Castegnaro M, Stefanovic V. New molecular and field evidences for the implication of mycotoxins but not aristolochic acid in human nephropathy and urinary tract tumor. Mol. Nutr. Food Res. 2007 51 : 1131 1146.
60. Abouzied MM, Horvath AD, Podlesny PM et al. Ochratoxin A concentrations in food and feed from a region with Balkan Endemic Nephropathy. Food Addit. Contam. 2002 19 : 755 764.
61. Radic B, Fuchs R, Peraica M, Lucic A. Ochratoxin A in human sera in the area with endemic nephropathy in Croatia. Toxicol. Lett. 1997 91 : 105 109.
62. Stefanovic V, Polenakovic M. Fifty years of research in balkan endemic nephropathy: Where are we now? Nephron Clin. Pract. 2009 112 : c51 6.
63. Grollman AP, Shibutani S, Moriya M et al. Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc. Natl. Acad. Sci. USA 2007 104 : 12129 12134.
64. de Jonge H, Vanrenterghem Y. Aristolochic acid: The common culprit of Chinese herbs nephropathy and Balkan endemic nephropathy. Nephrol. Dial. Transplant. 2008 23 : 39 41.
65. Debelle FD, Vanherweghem JL, Nortier JL. Aristolochic acid nephropathy: A worldwide problem. Kidney Int. 2008 74 : 158 169.
66. Che CT, Ahmed MS, Kang SS et al. Studies on Aristolochia III. Isolation and biological evaluation of constituents of Aristolochia indica roots for fertility-regulating activity. J. Nat. Prod. 1984 47 : 331 341.
67. Schmeiser HH, Stiborova M, Arlt VM. Chemical and molecular basis of the carcinogenicity of Aristolochia plants. Curr. Opin. Drug Discov. Devel. 2009 12 : 141 148.
68. Stiborova M, Frei E, Arlt VM, Schmeiser HH. The role of biotransformation enzymes in the development of renal injury and urothelial cancer caused by aristolochic acid: Urgent questions and difficult answers. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech. Repub. 2009 153 : 5 11.
69. Nortier JL, Schmeiser HH, Muniz Martinez MC et al. Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure. Nephrol. Dial. Transplant. 2003 18 : 426 428.
70. Debelle FD, Nortier JL, De Prez EG et al. Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats. J. Am. Soc. Nephrol. 2002 13 : 431 436.
71. Schmeiser HH, Schoepe KB, Wiessler M. DNA adduct formation of aristolochic acid I and II in vitro and in vivo. Carcinogenesis 1988 9 : 297 303.
72. Gao R, Zheng F, Liu Y, Zheng D, Li X, Bo Y. Aristolochic acid I-induced apoptosis in LLC-PK1 cells and amelioration of the apoptotic damage by calcium antagonist. Chin. Med. J. (Engl.) 2000 113 : 418 424.
73. Li B, Li XM, Zhang CY, Wang X, Cai SQ. [Injury in renal proximal tubular epithelial cells induced by aristololactam I]. Zhongguo Zhong Yao Za Zhi 2004 29 : 78 83.
74. Wen YJ, Su T, Tang JW et al. Cytotoxicity of phenanthrenes extracted from Aristolochia contorta in human proximal tubular epithelial cell line. Nephron Exp. Nephrol. 2006 103 : e95 e102.
75. Yang L, Li XM, Wang HY. [A comparative study of manchurian Dutchmanspipe and antibiotics induced acute tubular necrosis in renal cellular biological features]. Zhongguo Zhong Xi Yi Jie He Za Zhi 2003 23 : 329 334.
76. Lebeau C, Debelle FD, Arlt VM et al. Early proximal tubule injury in experimental aristolochic acid nephropathy: Functional and histological studies. Nephrol. Dial. Transplant. 2005 20 : 2321 2332.
77. Stiborova M, Frei E, Hodek P, Wiessler M, Schmeiser HH. Human hepatic and renal microsomes, cytochromes P450 1A1/2, NADPH:cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer. Int. J. Cancer 2005 113 : 189 197.
78. Stiborova M, Frei E, Wiessler M, Schmeiser HH. Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: Evidence for reductive activation by cytochromes P450 1A1 and 1A2. Chem. Res. Toxicol. 2001 14 : 1128 1137.
79. Stiborova M, Frei E, Breuer A, Wiessler M, Schmeiser HH. Evidence for reductive activation of carcinogenic aristolochic acids by prostaglandin H synthase - (32)P-postlabeling analysis of DNA adduct formation. Mutat. Res. 2001 493 : 149 160. (Pubitemid 32539438)
80. Fernando RC, Schmeiser HH, Scherf HR, Wiessler M. Formation and persistence of specific purine DNA adducts by 32P-postlabelling in target and non-target organs of rats treated with aristolochic acid I. IARC Sci. Publ. 1993 167 171.
81. Lord GM, Hollstein M, Arlt VM et al. DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy. Am. J. Kidney Dis. 2004 43 : e11 17.
82. Stiborova M, Frei E, Schmeiser HH. Biotransformation enzymes in development of renal injury and urothelial cancer caused by aristolochic acid. Kidney Int. 2008 73 : 1209 1211.
83. Sistkova J, Hudecek J, Hodek P, Frei E, Schmeiser HH, Stiborova M. Human cytochromes P450 1A1 and 1A2 participate in detoxication of carcinogenic aristolochic acid. Neuro. Endocrinol. Lett. 2008 29 : 733 737.
84. Xiao Y, Ge M, Xue X et al. Hepatic cytochrome P450s metabolize aristolochic acid and reduce its kidney toxicity. Kidney Int. 2008 73 : 1231 1239.
85. Toncheva DI, Von Ahsen N, Atanasova SY, Dimitrov TG, Armstrong VW, Oellerich M. Identification of NQO1 and GSTs genotype frequencies in Bulgarian patients with Balkan endemic nephropathy. J. Nephrol. 2004 17 : 384 389.
86. Jha V. Current status of chronic kidney disease care in South-East Asia. Semin. Nephrol. 2009 29 : 487 496.
87. Bandara JM, Senevirathna DM, Dasanayake DM, Herath V, Abeysekara T, Rajapaksha KH. Chronic renal failure among farm families in cascade irrigation systems in Sri Lanka associated with elevated dietary cadmium levels in rice and freshwater fish (Tilapia). Environ. Geochem. Health 2008 30 : 465 478.
88. Wanigasuriya KP, Peiris-John RJ, Wickremasinghe R, Hittarage A. Chronic renal failure in North Central Province of Sri Lanka: An environmentally induced disease. Trans. R. Soc. Trop. Med. Hyg. 2007 101 : 1013 1017.
89. Lightstone L, Rees AJ, Tomson C, Walls J, Winearls CG, Feehally J. High incidence of end-stage renal disease in Indo-Asians in the UK. Q. J. Med. 1995 88 : 191 195.
90. Mani MK. Chronic renal failure in India. Nephrol. Dial. Transplant. 1993 8 : 684 689 discussion 83.
91. Perkovic V, Cass A, Patel AA et al. High prevalence of chronic kidney disease in Thailand. Kidney Int. 2008 73 : 473 479.